ライフサイエンスコーパス: stress test

1 s of resolution and submit the methods to a "stress test".

2 e ranges of these values during the exercise stress test.

3 months, and 12 to 13 months after the prior stress test.

4 cular events than those who attained maximal stress test.

5 effective than a pathway that mandates a CMR stress test.

6 fting, congestive heart failure, or abnormal stress test.

7 t PCI for either stable angina or a positive stress test.

8 m, echocardiogram and, if available, nuclear stress test.

9 repeat intervention for chest pain/positive stress test.

10 ore and after completion of the Trier Social Stress Test.

11 d greater glycolytic flux in a bioenergetics stress test.

12 erica, MA, USA) during specifically designed stress tests.

13 y during spontaneous respiration and dynamic stress tests.

14 1.05-1.45) were also more likely to receive stress tests.

15 ars of PCI, with one third undergoing repeat stress tests.

16 sured at baseline and following the 3 mental stress tests.

17 n during spontaneous respiration and dynamic stress tests.

18 n during spontaneous respiration and dynamic stress tests.

19 ithout a CAD history presenting for exercise stress tests.

20 identify predictors of preoperative cardiac stress testing.

21 of patients were asymptomatic at the time of stress testing.

22 ients who underwent unnecessary preoperative stress testing.

23 inducible myocardial ischemia during cardiac stress testing.

24 % CI: 1.03-1.32) were positive predictors of stress testing.

25 d the rate of observation unit admission for stress testing.

26 ferences were driving the decision to obtain stress testing.

27 ary end point was major adverse event during stress testing.

28 dergo observation unit admission and cardiac stress testing.

29 related spending than patients who underwent stress testing.

30 c, often requiring prolonged observation and stress testing.

31 tential effectiveness of novel multimodality stress testing.

32 racteristics were associated with receipt of stress testing.

33 ociated with a decreased likelihood of prior stress testing.

34 heart disease who underwent symptom-limited stress testing.

35 te lesions or non-diagnostic scans underwent stress testing.

36 cancer (total, N = 82) had undergone cardiac stress testing.

37 iness in the selection of shock scenarios in stress testing.

38 ional impairment and choice of pharmacologic stress testing.

39 t repeat revascularization within 60 days of stress testing.

40 pharmacologic vasodilators used for cardiac stress testing.

41 chest pain evaluation, and repeat imaging or stress testing.

42 Spearman rank correlation coefficient during stress tests (0.89) and after stress relaxation (0.86).

43 .2% required echocardiography, 1.7% exercise stress test, 1.2% Holter, 1.2% cardiac magnetic resonanc

44 e of three different conditions prior to the stress test: 1) relaxing music ('Miserere', Allegri) (RM

45 ared with those obtained during an adenosine stress test (140 mug/kg/min).

46 , electrophysiology study or ablation (34%), stress testing (16%), and lead revision (11%).

47 with no cardiac indications for preoperative stress testing, 3.75% (N = 2803) received stress testing

48 During stress testing, 42 patients (14%) developed perfusion de

49 aphy angiography [CTA], 52% female; 4,466 to stress testing, 53% female), we assessed the relationshi

50 y to be admitted to the observation unit for stress testing (58% versus 77%; absolute difference, 19%

51 na (53.8%), low-risk ischemia on noninvasive stress testing (71.6%), or suboptimal (</=1 medication)

52 l patients were more likely to have abnormal stress tests (90% versus 43%; P=0.01) and had more exten

53 rding to both objective criteria (a negative stress test, a negative pad test, and no retreatment) an

54 ts possibly safe for early discharge without stress testing, a strategy that could have tremendous he

55 atistically significant higher prevalence of stress test abnormalities was found among left (27 of 46

56 al tachycardia in one third of GWI subjects (Stress Test Activated Reversible Tachycardia, START).

57 were exposed to a standardized psychosocial stress test after having been randomly assigned to one o

58 tudy was to determine the pattern of cardiac stress testing after coronary revascularization in commu

59 ensus as to the appropriate role of elective stress testing after coronary revascularization, more th

60 ittle is known about the patterns of cardiac stress testing after PCI in the single-payer Canadian he

61 Rates of stress testing after PCI within integrated healthcare sy

62 use criteria recommendations against routine stress testing after PCI.

63 tion of patients most likely to benefit from stress testing after PCI.

64 Stress testing after percutaneous coronary intervention

65 upport the need to define better the role of stress testing after recent revascularization.

66 Most stress tests after PCI were performed with nuclear imagi

67 ciation between physician billing and use of stress testing, after adjusting for patient and other ph

68 giography and repeat revascularization after stress testing also were examined.

69 ive: To determine trends in rates of cardiac stress testing among a large and diverse cohort of comme

70 Adjusted odds ratios (ORs) of nuclear stress testing among patients treated by physicians who

71 Thirty-four patients who had a nuclear stress test and invasive angiography were included in th

72 also underwent a standard laboratory social stress test and provided saliva samples for cortisol ass

73 emic heart disease (SIHD) to consider use of stress testing and anatomic diagnostic procedures.

74 Both stress testing and referring patients out for care doubl

75 Nuclear stress testing and stress echocardiography testing follo

76 evel variation in risk-standardized rates of stress testing and the association with 1-year mortality

77 ate risk of coronary heart disease underwent stress testing and those with a positive test were treat

78 st cancer who subsequently underwent cardiac stress testing and/or catheterization for cardiovascular

79 ects (n=7) during 15-minute cardiac exercise stress tests and 30 minutes after stress relaxation in 3

80 ion treatment (RT) were screened for cardiac stress tests and catheterizations performed after RT.

81 ructed and validated in vitro by temperature stress tests and in vivo by evaluation of attenuation in

82 iac magnetic resonance (including dobutamine stress testing), and the Short Form-36 questionnaire.

83 these inappropriate patients had no previous stress test, and approximately 90% of inappropriate pati

84 derwent cardiac magnetic resonance, exercise stress test, and review of medical history.

85 ms associated with the condition, a positive stress test, and urethral hypermobility.

86 ognitive performance during the Trier Social Stress Test, and used self-report questionnaires to asse

87 ame applies to clinical parameters, exercise stress testing, and other imaging modalities used in AS

88 nfer enhanced tolerance to the other abiotic stresses tested, and approximately 50% rendered plants m

89 gesting opportunities to optimize the use of stress testing are still present in integrated healthcar

90 it is not known whether declines in cardiac stress testing are universal or are confined to certain

91 The utility of cardiac stress testing as a risk-stratification tool before kidn

92 ed HEART score </=3, early discharge without stress testing as compared with transfer to an observati

93 cardiologists rated 256 (64%) of 400 nuclear stress tests as appropriate, 68 (18%) as uncertain, 55 (

94 Each subject underwent an exercise stress test at the start and finish of each phase.

95 cutive cohort of patients undergoing nuclear stress testing at an academic medical center.

96 men, displacement behaviour during a social stress test attenuated the relationship between anxiety

97 lthy individuals exposed to the Trier Social Stress Test (B=-173.40, t=-2.324, p-value=0.023).

98 dencies among financial institutions, we run stress-test based on Group DebtRank.

99 consecutive patients who underwent exercise stress testing before and after completion of a phase 2

100 cal risk factors) should not undergo cardiac stress testing before elective noncardiac, nonvascular s

101 objective was to evaluate whether receipt of stress testing before elective PCI predicts mortality.

102 es advise testing for ischemia, such as with stress testing, before elective percutaneous coronary in

103 d/anxiety on the presence of ischemia during stress testing by CAD history in a stratified analyses,

104 This reverse stress test can be used to identify the potential trigge

105 e reduced survival during in vivo dobutamine stress testing compared to controls.

106 pothesized that listening to RM prior to the stress test, compared to SW or R would result in a decre

107 risk scores with an echocardiogram, exercise stress test, computerized tomographic coronary angiogram

108 ce and ultrahigh stability under accelerated stress test conditions and can be considered as a promis

109 val, and displayed ventricular ectopy during stress testing consistent with CPVT.

110 ms, but neither risk factors nor noninvasive stress tests, contributed to predicting a pathological t

111 iduals aged 55 to 64 years, rates of cardiac stress testing decreased by 12.3% from 2005 (7894 tests;

112 The hospital-level risk-standardized rate of stress testing differed significantly from the average a

113 ctrocardiography, Holter recording, exercise stress test, echocardiography, and/or cardiac magnetic r

114 ey were prospectively assessed with exercise stress test (EST), stress echocardiogram (SE), and stres

115 ary cortisol response to standardized mental stress tests (exposure) and hs-cTnT plasma concentration

116 rt rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of v

117 Stress test findings did not predict obstructive CAD on

118 ting status, underwent a battery of 3 mental stress tests followed by a treadmill test.

119 escribed in implementing a new multimodality stress test for accurate correlation of complementary fu

120 stic target of rapamycin (mTOR) represents a stress test for tumor cells and T cells.

121 ed between 1990 and 2002 for symptom-limited stress testing for evaluation of known or suspected coro

122 this model could be useful for systemic risk stress testing for financial systems.

123 here was a 3.0% increase in rates of cardiac stress testing from 2005 (3486 tests; 95% CI, 3458-3514)

124 ing (exercise electrocardiography or nuclear stress testing) from 2009 to 2015.

125 n early AKI, urine output after a furosemide stress test (FST), which involves intravenous administra

126 Patients who underwent pre-PCI stress testing had a 13% lower risk of mortality than th

127 Paraquat, a prooxidant widely used in stress tests, had a strong anorexigenic effect.

128 ate, 56.7% were asymptomatic/had no previous stress test/had low or intermediate global coronary arte

129 s, and 7.3% were symptomatic/had no previous stress test/had low pretest probability.

130 The proposed new multimodality stress test has the potential for simultaneously improvi

131 Thus, CMR perfusion stress testing has been deemed appropriate for the evalu

132 to test the hypotheses that ischemia during stress testing has prognostic value and identifies those

133 ter a period of rapid growth, use of cardiac stress testing has recently decreased among Medicare ben

134 higher risk of mortality than those in high stress test/high PCI regions (adjusted hazard ratio, 1.1

135 Patients in low stress test/high PCI regions had a 14% higher risk of mo

136 test/high PCI, low stress test/low PCI, low stress test/high PCI, and high stress/low PCI regions.

137 regions and categorized into 4 groups: high stress test/high PCI, low stress test/low PCI, low stres

138 ary artery bypass grafting (CABG), angina at stress testing, hypertension,and, in women, beta-blockin

139 Further stress tests identified additional incidental mutations,

140 test, with 38 267 (34.0%) undergoing repeat stress testing (ie, >1 stress test) within 2 years.

141 icipants underwent a symptom-limited maximal stress test in 1992.

142 Myocardial ischemia was induced during stress testing in 256 patients (64% of the study populat

143 sive review of the current available data on stress testing in aortic stenosis and subsequently summa

144 Drug Administration approved regadenoson for stress testing in conjunction with MPI.

145 s known regarding the use of routine cardiac stress testing in coronary artery bypass grafting or per

146 Cardiac stress testing in patients at low risk for acute coronar

147 al longitudinal strain (LV-GLS) and exercise stress testing in risk stratification of patients with s

148 n contrast to declines in the use of cardiac stress testing in some health care systems, we observed

149 tic information derived from anatomic versus stress testing in stable men and women with suspected co

150 ve stress testing, 3.75% (N = 2803) received stress testing in the 2 months before surgery.

151 In the VA, nearly 40% of patients underwent stress testing in the 2 years after PCI, which is a thir

152 We examined the use of preoperative stress testing in the subset of patients with no diagnos

153 without inducible ischemia during dobutamine stress testing in whom one might otherwise assume a favo

154 normal heart rate (HR) response to exercise stress testing in women is poorly understood, given that

155 AT) at baseline and following 3 acute mental stress tests in female patients with ABS (n = 12, at lea

156 Classical genetics, using temperature stress tests in vitro combined with nucleotide sequencin

157 at rest and at peak of low-dose Dipyridamole stress test, in the assessment of significant coronary a

158 iduals aged 25 to 34 years, rates of cardiac stress testing increased 59.1% from 2005 (543 tests; 95%

159 The rate of preoperative stress testing increased from 1.72% in 1996 to 6.44% in

160 Oxidative stress test indicated ZnO-induced oxidative damage was e

161 Trier Social Stress Test-induced increases in IL-6 and NF-kappaB DNA-

162 During in vitro stress tests involving serial passage at incrementally i

163 Pre-PCI stress testing is associated with lower mortality in pat

164 However, pre-PCI stress testing is not always done; the implications of t

165 Because cardiopulmonary stress testing is not available in every hospital, tread

166 Although noninvasive stress testing is often done to screen for CAD in asympt

167 The objective of cardiac stress testing is to detect coronary artery disease (CAD

168 a robust predictor of clinical outcomes, and stress testing is used in current practice paradigms to

169 Exercise "stress" testing is a screening tool used to determine th

170 incidental findings, and when performed with stress testing, its incremental cost-effectiveness ratio

171 ection remote from the scanner, such as in a stress testing laboratory or chest pain unit.

172 nto 4 groups: high stress test/high PCI, low stress test/low PCI, low stress test/high PCI, and high

173 On exercise stress test, maximum oxygen consumption was 76+/-16% pre

174 ere consistent, suggesting that the in vitro stress test may be used as a method to predict the liabi

175 t that observed trends in the use of cardiac stress testing may have been driven more by unique chara

176 development of diastolic dysfunction during stress testing may improve the recognition of CAD.

177 (CPT) and endothelium-independent (adenosine stress test) MBF reserve in a single study.

178 Noninvasive stress testing might guide the use of aspirin and statin

179 Use of other stress testing modalities increased 65.5% from 2006 (55

180 ctive than a physicians' ability to select a stress test modality.

181 visit involving exposure to the Trier Social Stress Test modified to maximize between-sex differences

182 Use and timing of stress testing more than 90 days after revascularization

183 using a modified version of the Trier Social Stress Test (n = 55).

184 aging test (n=60) or (2) a provider-selected stress test (n=60: stress echo [62%], CMR [32%], cardiac

185 ersus management in an observation unit with stress testing (n=52).

186 is >50% on angiography, abnormal correlative stress test, new MI, or death.

187 3-day diary), a negative cough and Valsalva stress test, no self-reported symptoms, and no retreatme

188 Of the tests performed for ischemic CAD, stress testing (nuclear stress testing or stress echocar

189 lihood of black patients receiving a cardiac stress test (odds ratio, 0.91 [95% CI, 0.69 to 1.21]) th

190 velop a reliable, objective, within-subject 'stress-test' of anxious responding.

191 disease, spontaneous respiration and dynamic stress tests on pulmonary artery wave propagation and re

192 H patients who underwent a radionuclide (RN) stress test or a dobutamine stress echocardiogram (DSE).

193 ts underwent pharmacological radionucleotide stress test or dobutamine stress echocardiography before

194 ment options (observation unit admission and stress testing or 24-72 hours outpatient follow-up).

195 primary outcome, objective cardiac testing (stress testing or angiography), and secondary outcomes,

196 ally intermediate stenoses in the absence of stress testing or in the presence of discordant stress t

197 utcomes, but performing CCTA-with or without stress testing or performing stress single-photon emissi

198 ed for ischemic CAD, stress testing (nuclear stress testing or stress echocardiography) was performed

199 assigned to a stress condition (Trier Social Stress Test) or a control condition.

200 sting (exercise electrocardiography, nuclear stress testing, or stress echocardiography).

201 The remainder were Stress Test Originated Phantom Perception (STOPP) subjec

202 howed a significant increase in preoperative stress testing over time.

203 The remaining 25% of patients required stress testing, owing to intermediate severity lesions o

204 -menopausal controls, following acute mental stress testing (p < 0.05).

205 Cardiac stress testing, particularly with imaging, has been the

206 ures: Age- and sex-adjusted rates of cardiac stress tests per calendar quarter (reported as number of

207 g PCI at 55 VA hospitals, 2239 (21.8%) had a stress test performed within 1 year of PCI and 3902 (37.

208 Missing data on noninvasive stress tests present a challenge in the application of t

209 more PCIs per year were less likely to have stress testing prior to PCI (AOR, 0.84; 95% CI, 0.77-0.9

210 % CI, 1.09-1.46) increased the likelihood of stress testing prior to PCI.

211 ditis protocol (group A), 10 patients with a stress-testing protocol (group B), and six patients with

212 Pharmacological cardiac stress testing provided excellent risk stratification in

213 For example, routine perioperative stress testing provides no incremental diagnostic yield

214 %) hospitals significantly above the average stress testing rate.

215 ion among the hospital referral regions with stress test rates ranging from 22.1% to 70.6% (national

216 However, stress testing rates varied across VA hospitals, suggest

217 Hospital-level risk-standardized stress testing rates were not significantly correlated w

218 Cardiac stress test referrals and inappropriate use.

219 ant heart disease and medical comorbidities, stress testing represents a reasonable strategy to help

220 ikely to have a positive CTA than a positive stress test result (16% vs. 14%; adjusted odds ratio: 1.

221 0% stenosis) was less likely than a positive stress test result (8% vs. 12%; adjusted odds ratio: 0.6

222 h subsequent clinical events than a positive stress test result (CTA-adjusted hazard ratio of 5.86 vs

223 Patients with a positive stress test result (n=67) underwent coronary angiogram,

224 h subsequent clinical events than a positive stress test result in men, although this difference was

225 activity-limiting angina, 77% had a positive stress test result, and 29% had had previous MI.

226 ly than those who did not to have a positive stress test result, but angina was similar in both group

227 ess testing or in the presence of discordant stress test results and angiographic findings.

228 onducted to evaluate the correlation between stress test results and coronary computed tomography ang

229 cardiac outcomes between those with negative stress test results and those with positive stress test

230 ar after transplant, the group with positive stress test results experienced more cardiac events (34.

231 ease (CAD) but negative exercise or chemical stress test results might have mental stress-induced isc

232 Demographics, risk factors, symptoms, and stress test results were correlated with obstructive CAD

233 Negative CTA and stress test results were equally likely to predict an ev

234 Stress test results were not predictive.

235 Baseline, 6-month exercise stress test results, and anthropometrics were examined r

236 testing in patients needing adjudication of stress test results.

237 0.001) compared with the group with negative stress test results.

238 stress test results and those with positive stress test results.

239 AD and negative exercise or chemical nuclear stress test results.

240 In this diabetic population, stress testing showed positive and negative predictive v

241 s most suggestive of ACS were prior abnormal stress test (specificity, 96%; LR, 3.1 [95% CI, 2.0-4.7]

242 Patterns of noninvasive stress test (ST) and invasive coronary angiography (CA)

243 hoton emission computed tomographic exercise stress test (standard Bruce Protocol) and underwent a ps

244 ronary heart disease, regardless of exercise stress testing status, underwent a battery of 3 mental s

245 hown that a cardiac magnetic resonance (CMR) stress test strategy implemented in an observation unit

246 among lower-risk patients if a mandatory CMR stress test strategy was more effective than a physician

247 which they participated in the Trier Social Stress Test Task.

248 ngly, among the various hormones and abiotic stresses tested, temperature stress (cold and heat) dram

249 pulmonary regurgitant fraction, on exercise stress test the 22q11.2DS had significantly lower percen

250 s can undergo a carefully monitored exercise stress test to confirm both their asymptomatic status an

251 have stable ischemic heart disease, cardiac stress testing to assess the risk for death or myocardia

252 gression from electrocardiographically based stress testing to current SPECT and PET technologies has

253 Patients underwent exercise stress testing to determine peak metabolic equivalents (

254 l, basic laboratories, and electrocardiogram stress testing to include CPET.

255 ere used to test the relationship of pre-PCI stress testing to survival.

256 y statins are available, noninvasive cardiac stress testing to target preventive medications is not c

257 Using an in vivo "stress test" to challenge CD19-targeted T cells, we stud

258 o an experimental stressor, the Trier Social Stress Test (TSST), in 208 offspring of parents with moo

259 male participants completed the Trier Social Stress Test (TSST).

260 he initial trial in patients with a positive stress test undergoing major vascular surgery demonstrat

261 -blockers and those patients with a positive stress test undergoing vascular surgery.

262 National growth in cardiac stress test use can largely be explained by population a

263 Physician decision making about cardiac stress test use does not seem to contribute to racial/et

264 nfluence of Medicare eligibility on rates of stress testing use in the VA, we excluded Medicare eligi

265 om were women) who underwent cardiopulmonary stress testing using a modified Naughton protocol.

266 icine interns) classified individual nuclear stress tests using the 2009 Appropriate Use Criteria.

267 satisfaction, rates of positive provocative stress tests, voiding dysfunction, or adverse events.

268 of U.S. ambulatory visits in which a cardiac stress test was ordered or performed increased from 28 p

269 The cumulative incidence of nuclear stress testing was 12.6% (95% CI, 12.0%-13.2%), 8.8% (95

270 red with transfer to an observation unit for stress testing was associated with significant reduction

271 agnetic resonance imaging, ECG, and exercise stress testing, was performed in 205 FA patients.

272 Among a panel of hormones and stresses tested, we found that, in addition to PA, the f

273 mine) responses to a transport and isolation stress test were also measured.

274 % of inappropriate patients with no previous stress test were asymptomatic with low or intermediate g

275 The results of a recent exercise stress test were normal; he runs 10 km 4 or 5 times per

276 ho were undergoing CCTA within 3 months of a stress test were studied.

277 nary angiography and revascularization after stress testing were ascertained.

278 Population-based rates of elective PCI and stress testing were calculated for 306 hospital referral

279 Spikes in incidence of repeat stress testing were observed at 3 to 4 months, 6 to 7 mo

280 Patients who underwent stress testing were younger, had less medical comorbidit

281 Results: A total of 2085591 cardiac stress tests were performed among 32921838 persons (mean

282 Assuming results for noninvasive stress tests when data were missing, in the best-case sc

283 xes or ventricular tachycardia upon exercise stress tests when sinus rate exceeded 99+/-17 beats per

284 ry artery disease risk, 36.0% had a previous stress test with low-risk findings and no symptoms, and

285 rred for invasive coronary angiography after stress testing with myocardial perfusion positron emissi

286 rred for invasive coronary angiography after stress testing with myocardial perfusion positron emissi

287 Cardiac stress tests with imaging comprised a growing portion of

288 of training can effectively identify nuclear stress tests with inappropriate indications.

289 ed technologies: resting echocardiograms and stress tests with nuclear imaging.

290 ith PCI, 67 442 (59.8%) underwent at least 1 stress test, with 38 267 (34.0%) undergoing repeat stres

291 atients in community practice had at least 1 stress test within 24 months of revascularization.

292 ting procedures), 59% had at least 1 cardiac stress test within 24 months.

293 e appropriate use criteria considers cardiac stress testing within 2 years after percutaneous coronar

294 METHODS AND Frequency and timing of cardiac stress testing within 2 years of PCI performed between A

295 re than half of all patients undergo cardiac stress testing within 2 years of PCI, with one third und

296 ive incidence of nuclear or echocardiography stress testing within 30 days of the index cardiac-relat

297 es, 44.5% (n = 10 629) of patients underwent stress testing within the 90 days prior to elective PCI.

298 Incidence of nuclear and echocardiographic stress tests within 30 days of an index cardiac-related

299 0%) undergoing repeat stress testing (ie, >1 stress test) within 2 years.

300 s data, 2803 patients underwent preoperative stress testing without any indications.